Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
filingDate |
1988-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1991-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7db7f1318f02005d93846176d48b61f |
publicationDate |
1991-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5047427-A |
titleOfInvention |
Treatment for secondary diabetes effects |
abstract |
The invention provides a method to ameliorate or prevent the secondary damaging effects of diabetes by affecting oxidation of sorbitol in insulin-independent cells. Pyruvate salts and/or NAD+ precursors administered in a repetitive protocol provide protection against these secondary effects. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006281748-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8829051-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5886040-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331288-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5965167-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11160775-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008161255-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011043806-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006100189-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5508308-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6608196-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751304-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005115379-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9737511-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7012086-B1 |
priorityDate |
1988-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |